Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Yang Xiong, Yangchang Zhang, Fuxun Zhang, Changjing Wu, Feng Qin & Jiuhong Yuan. (2022) Reduced sleep duration increases the risk of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in middle-aged and elderly males: a national cross-sectional study. The Aging Male 25:1, pages 159-166.
Read now
Read now
Sandro La Vignera, Antonio Aversa, Rossella Cannarella, Rosita A. Condorelli, Ylenia Duca, Giorgio I. Russo & Aldo E. Calogero. (2021) Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects. Expert Opinion on Pharmacotherapy 22:2, pages 179-189.
Read now
Read now
Anton Wong & Wasim Mahmalji. (2020) The role of Rezūm ™ team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review. The Aging Male 23:5, pages 1620-1626.
Read now
Read now
Marcello H. A. Da Silva, Jorge L. Medeiros$suffix/text()$suffix/text(), Waldemar S. Costa, Francisco J. B. Sampaio & Diogo B. De Souza. (2020) Effects of the dutasteride and sildenafil association in the penis of a benign prostatic hyperplasia animal model. The Aging Male 23:5, pages 1009-1015.
Read now
Read now
Lorna K. P. Suen, Chao Hsing Yeh, Simon K. W. Yeung & Jerry W. F. Yeung. (2020) Is the combined auriculotherapy approach superior to magneto-auriculotherapy alone in aging males with lower urinary tract symptoms? A randomized controlled trial. The Aging Male 23:5, pages 544-555.
Read now
Read now
Daisuke Watanabe, Akemi Yamashita, Kunihisa Miura & Akio Mizushima. (2020) Effects on sexual function in Japanese patients with benign prostatic hyperplasia upon switching from combination therapy with α1 blocker and dutasteride to combination therapy with tadalafil and dutasteride. The Aging Male 23:5, pages 501-506.
Read now
Read now
Radosław B. Maksym, Anna Kajdy & Michał Rabijewski. (2019) Post-finasteride syndrome – does it really exist?. The Aging Male 22:4, pages 250-259.
Read now
Read now
Aldo E. Calogero, Giovanni Burgio, Rosita A. Condorelli, Rossella Cannarella & Sandro La Vignera. (2019) Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. The Aging Male 22:1, pages 12-19.
Read now
Read now
Aldo E. Calogero, Giovanni Burgio, Rosita A. Condorelli, Rossella Cannarella & Sandro La Vignera. (2018) Treatment of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. The Aging Male 21:4, pages 272-280.
Read now
Read now
Aldo E. Calogero, Giovanni Burgio, Rosita A. Condorelli, Rossella Cannarella & Sandro La Vignera. (2018) Lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction: from physiology to clinical aspects. The Aging Male 21:4, pages 261-271.
Read now
Read now
Kirill Kosilov, Irina Kuzina, Vladimir Kuznetsov, Yuliya Gainullina, Liliya Kosilova, Alexandra Prokofyeva & Sergey Loparev. (2018) Cognitive functions and health-related quality of life in men with benign prostatic hyperplasia and symptoms of overactive bladder when treated with a combination of tamsulosin and solifenacin in a higher dosage. The Aging Male 21:2, pages 121-129.
Read now
Read now
Chen-Pang Hou, Yu-Hsiang Lin, Tien-Hsing Chen, Phei-Lang Chang, Horng-Heng Juang, Chien-Lun Chen, Pei-Shan Yang & Ke-Hung Tsui. (2018) Transurethral resection of the prostate achieves favorable outcomes in stroke patients with symptomatic benign prostate hyperplasia. The Aging Male 21:1, pages 9-16.
Read now
Read now
Xiaoqiang Qian, Ding Xu, Hailong Liu, Xiaoling Lin, Yongjiang Yu, Jian Kang, Xujun Sheng, Jianfeng Xu, Siqun Zheng, Danfeng Xu & Jun Qi. (2017) Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist. The Aging Male 20:4, pages 250-256.
Read now
Read now
Antonio D. Bardoli, Will St J. Taylor & Wasim Mahmalji. (2017) Can the UroLift prostatic implant device treat the symptoms of benign prostatic hypertrophy, avoid sexual dysfunction and reduce hospital TURP waiting times? A single centre, single surgeon experience and review of the literature. The Aging Male 20:3, pages 192-197.
Read now
Read now
Onder Canguven, Raidh A. Talib, Walid El-Ansari, Ahmed Shamsoddini, Mahmoud Salman & Abdulla Al-Ansari. (2016) RigiScan data under long-term testosterone therapy: improving long-term blood circulation of penile arteries, penile length and girth, erectile function, and nocturnal penile tumescence and duration. The Aging Male 19:4, pages 215-220.
Read now
Read now
Articles from other publishers (25)
Herman H. J. Leliefeld, Frans M. J. Debruyne & Yakov Reisman. (2023) The post-finasteride syndrome: possible etiological mechanisms and symptoms. International Journal of Impotence Research.
Crossref
Crossref
Murat Gül, Mikkel Fode, Ahmet Urkmez, Paolo Capogrosso, Marco Falcone, Selcuk Sarikaya, Ioannis Sokolakis, Afonso Morgado, Andrey Morozov, Maarten Albersen, Giorgio Ivan Russo & Ege Can Serefoglu. (2023) A clinical guide to rare male sexual disorders. Nature Reviews Urology.
Crossref
Crossref
Cosimo De Nunzio, Andrea Salonia, Mauro Gacci & Vincenzo Ficarra. (2022) The Role of Combination Therapy with α-Blockers and Hexanic Extract of Serenoa repens in the Treatment of LUTS/BPH. Journal of Clinical Medicine 11:23, pages 7169.
Crossref
Crossref
Ingrid W. Koëter, Joost M. Vermue & Patrick W. Dielissen. (2022) Urologie en mannen die seks hebben met mannenUrology and men who have sex with men. Tijdschrift voor Urologie 12:6-7, pages 118-125.
Crossref
Crossref
S. I. Gamidov, R. I. Ovchinnikov, A. Yu. Popova & T. V. Shatylko. (2021) Risk factors for erectile dysfunction: known and unexpected facts (review). Andrology and Genital Surgery 22:4, pages 13-21.
Crossref
Crossref
Vincenzo Favilla, Rossella Cannarella, Federica Trovato, Giovanni Li Volti, Alfio Distefano, Enrico Grimaldi, Giuseppa La Camera, Sandro La Vignera, Rosita A. Condorelli, Aldo E. Calogero & Sebastiano Cimino. (2021) Effects of dutasteride on sex hormones and cerebrospinal steroids in patients treated for benign prostatic hyperplasia. Endocrine 73:3, pages 712-718.
Crossref
Crossref
Luis Fernando Valladales-Restrepo & Jorge Enrique Machado-Alba. (2020) Pharmacological treatment and inappropriate prescriptions for patients with erectile dysfunction. International Journal of Clinical Pharmacy 43:4, pages 900-908.
Crossref
Crossref
Cissa Azevedo, Caroline de Castro Moura, Hérica Pinheiro Corrêa, Bianca Bacelar de Assis, Luciana Regina Ferreira da Mata & Tânia Couto Machado Chianca. (2021) Auriculotherapy in adults and elderly people with lower urinary tract symptoms: an integrative review. Revista da Escola de Enfermagem da USP 55.
Crossref
Crossref
A. Sebastianelli, P. Spatafora, S. Morselli, L. Vignozzi, S. Serni, K. T. McVary, S. Kaplan, S. Gravas, C. Chapple & Mauro Gacci. (2020) Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED. Current Urology Reports 21:12.
Crossref
Crossref
Claus G. Roehrborn, Raymond C. Rosen, Michael J. Manyak, Juan Manuel Palacios‐Moreno, Timothy H. Wilson, Zrinka Lulic & François Giuliano. (2020) Men’s Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of a prospective, randomised, placebo‐controlled study. International Journal of Clinical Practice 74:5.
Crossref
Crossref
Matthias Oelke. 2020. Urologic Principles and Practice. Urologic Principles and Practice
127
150
.
Cosimo De Nunzio, Riccardo Lombardo, Antonio Maria Cicione & Andrea Tubaro. 2020. Urologic Principles and Practice. Urologic Principles and Practice
341
355
.
Jiakuan Liu, Tian Fang, Meiqian Li, Yuting Song, Junzun Li, Zesheng Xue, Jiaxuan Li, Dandan Bu, Wei Liu, Qinghe Zeng, Yidan Zhang, Shifeng Yun, Ruimin Huang & Jun Yan. (2019) Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5α-Reductase. Scientific Reports 9:1.
Crossref
Crossref
Dominik Abt, Janine Langenauer & Gautier Müllhaupt. (2019) Minimal-invasive Therapien zur Behandlung des benignen Prostatasyndroms – besser als Medikamente?Traitement mini-invasif du syndrome prostatique bénin – mieux que les médicaments?. Urologie in der Praxis 21:4, pages 140-146.
Crossref
Crossref
Raymond C. Rosen, Claus G. Roehrborn, Michael J. Manyak, Juan Manuel Palacios‐Moreno, Timothy H. Wilson, Zrinka Lulic & Francois Giuliano. (2018)
Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (
LUTS
) secondary to benign prostatic hyperplasia (
BPH
): A post hoc analysis of a prospective randomised placebo‐controlled study
. International Journal of Clinical Practice 73:9, pages 1-9.
Crossref
Crossref
Kevin T. McVary, Tyson Rogers, Joseph Mahon & Nikhil K. Gupta. (2018) Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia?. The Journal of Sexual Medicine 15:12, pages 1728-1738.
Crossref
Crossref
Nicole Tuong, Katy Reines, Matthew Mikula & Ryan Smith. (2018) Contemporary Review of BPH Medical and Surgical Treatments on Sexual Function. Current Sexual Health Reports 10:4, pages 293-304.
Crossref
Crossref
T. Bschleipfer & M. Burkart. (2018) Einfluss medikamentöser BPS-Therapie auf die sexuelle FunktionInfluence of medical BPS treatment on sexual function. Der Urologe 57:12, pages 1464-1471.
Crossref
Crossref
Abdulmaged M. Traish. (2018) The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption. Current Sexual Health Reports 10:3, pages 88-103.
Crossref
Crossref
Nikhil Gupta, Tyson Rogers, Bradley Holland, Sevann Helo, Danuta Dynda & Kevin T. McVary. (2018) Three-Year Treatment Outcomes of Water Vapor Thermal Therapy Compared to Doxazosin, Finasteride and Combination Drug Therapy in Men with Benign Prostatic Hyperplasia: Cohort Data from the MTOPS Trial. Journal of Urology 200:2, pages 405-413.
Crossref
Crossref
Carlo Terrone & Michele Billia. 2018. Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia. Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia
217
239
.
Aldo E. Calogero, Giovanni Burgio, Rosita A. Condorelli & Sandro La Vignera. 2018. Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia. Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia
51
88
.
Shankun Zhao, Tuo Deng, Lianmin Luo, Jiamin Wang, Ermao Li, Luhao Liu, Futian Li, Jintai Luo & Zhigang Zhao. (2017) Association Between Opioid Use and Risk of Erectile Dysfunction: A Systematic Review and Meta-Analysis. The Journal of Sexual Medicine 14:10, pages 1209-1219.
Crossref
Crossref
Tina Kiguradze, William H. Temps, Paul R. Yarnold, John Cashy, Robert E. Brannigan, Beatrice Nardone, Giuseppe Micali, Dennis Paul West & Steven M. Belknap. (2017) Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride. PeerJ 5, pages e3020.
Crossref
Crossref
A. García-Vega. (2016) Efectos secundarios de los inhibidores de 5-α reductasa en el tratamiento de hiperplasia prostática benigna. Revista Mexicana de Urología 76:5, pages 265-266.
Crossref
Crossref